Table 1.
Area(s) injected | Case | Tracer or virus | Concentration (% w/v or pfu/ml) | Number of injections | Vol injected (μl) | Survival time (d) |
---|---|---|---|---|---|---|
Conventional tracer experiments | ||||||
9m | F14 | RD | 10% | 17 | 1.7 | 12 |
9l | F27L | NY | 1% | 10 | 2.5 | 5 |
46d | F2 | DY | 2% | 24 | 2.4 | 7 |
46v | F2 | FB | 5% | 35 | 3.5 | 7 |
12l | F27R | FB | 5% | 11 | 2.75 | 5 |
Virus experiments | ||||||
10d | F20 | HSV1 | 1.2 × 1010 | 48 | 3.5 | 5 |
10d | F21R | HSV1 | 1.5 × 1010 | 39 | 3.5 | 5 |
9m | F19 | HSV1 | 8.5 × 1010 | 33 | 3.0 | 5 |
9m | F25 | HSV1 | 3.0 × 109 | 25 | 2.4 | 5 |
9l | F11L | HSV1 | 1.0 × 109 | 28 | 2.8 | 5 |
9l | F21L | HSV1 | 1.5 × 1010 | 38 | 3.5 | 5 |
46 | F1 | HSV1 | 1.1 × 108 | 42 | 2.1 | 5 |
46 | F6 | HSV1 | 2.5 × 108 | 59 | 3.0 | 5 |
46 | F11R | HSV1 | 1.0 × 109 | 56 | 5.0 | 5 |
46d | F24L | HSV1 | 1.0 × 1011 | 25 | 2.4 | 5 |
46d | F28L | HSV1 | 3.0 × 109 | 21 | 4.0 | 5 |
46v | F24R | HSV1 | 1.0 × 1011 | 23 | 2.3 | 5 |
46v | F28R | HSV1 | 3.0 × 109 | 19 | 3.8 | 5 |
12l | F12 | HSV1 | 1.0 × 109 | 29 | 2.9 | 5 |
12l | F27L | HSV1 | 3.0 × 109 | 17 | 3.4 | 5 |